Delaware Business Court Insider | News
By Ellen Bardash | July 15, 2021
"If you are trying to sell someone a service, but the negotiations are not going well, you cannot just provide the service anyway and demand money," Judge Stephanos Bibas wrote in a memorandum opinion in a dispute between an insurance company and a health care provider over payment for services.
By Greg Land | July 13, 2021
U.S. District Judge Steve Jones said the allegations that Caterpillar agreed to pay an engineer/inventor for the use of his backup electric starter technology, then stiffed him and had him fired, were sufficiently pleaded to survive a motion to dismiss.
By Jasmine Floyd | July 9, 2021
"Insurance companies have no protectable privacy right when they are coming to an insured house to inspect or appraise property," appellate lawyer Samuel Alexander said.
By Zack Needles | July 9, 2021
Skyrocketing material costs and supply chain breakdowns are just a few of the hurdles that have resulted in problematic construction projects and unhappy customers.
By Melea VanOstrand | July 7, 2021
"Make sure both spouses are protected, in that the property cannot be foreclosed upon until the last of the borrower dies," said one attorney involved in the case.
By Michael A. Mora | June 29, 2021
"It would violate the principles of collateral estoppel to allow appellants to relitigate this issue simply because they recharacterized their claim as one of bad faith rather than breach of contract," the federal appeals judges stated in the opinion.
By Meghann M. Cuniff | June 29, 2021
"The government's own description of its evidence presents such fascinating sparkle that the jury is likely to be diverted from ... its main inquiry: Did Avenatti divert funds to which he was not entitled?" U.S. District Judge James V. Selna wrote.
By Ellen Bardash | June 24, 2021
The case stems from a contract between Macrophage Therapeutics Inc., represented by Richard, Layton & Finger, and Michael M. Goldberg, the CEO of Navidea Biopharmaceuticals Inc. who was supposed to become CEO of its subsidiary, Macrophage.
Delaware Business Court Insider
By Ellen Bardash | June 24, 2021
The case stems from a contract between Macrophage Therapeutics Inc., represented by Richard, Layton & Finger, and Michael M. Goldberg, the CEO of Navidea Biopharmaceuticals Inc. who was supposed to become CEO of its subsidiary, Macrophage.
By Charles Toutant | June 24, 2021
The suit seeks reimbursement of the $120,000 in fees, as well as other compensatory damages, disgorgement of legal fees and costs paid to Hill Wallack in the Delaware case, and reimbursement of fees and costs for bringing the malpractice suit.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Title: Legal Counsel Reports to: Chief Executive Officer (CEO) FLSA Status: Exempt, Full Time Supervisory Responsibility: N/A Location: Remo...
Blume Forte Fried Zerres and Molinari 1 Main Street Chatham, NJ 07945Prominent Morris County Law Firm with a state-wide personal injury prac...
d Arcambal Ousley & Cuyler Burk, LLP, a well-established women-owned litigation firm, has an opening in our Parsippany, NJ office. We of...